William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
Go back to William Blair Reiterates Outperform Rating on Entrada Therapeutics (TRDA)| (NASDAQ: TRDA) | Delayed: 6.79 +0.02 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.77 | 52 Week High | $ | |||
| Open | $6.71 | 52 Week Low | $ | |||
| Day High | $6.90 | P/E | N/A | |||
| Day Low | $6.49 | EPS | $ | |||
| Volume | 352,598 | |||||

